Detalhe da pesquisa
1.
The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19.
Clinics (Sao Paulo)
; 77: 100130, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283138
2.
The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19
Clinics
; 77: 100130, 2022. tab
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1421232
3.
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.
United European Gastroenterol J
; 4(6): 784-793, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408996
4.
Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study.
Intest Res
; 13(3): 259-65, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26131001
5.
Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
J Crohns Colitis
; 9(7): 541-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820017